Cogent Biosciences Inc (NASDAQ: COGT) on Monday, soared 7.07% from the previous trading day, before settling in for the closing price of $15.13. Within the past 52 weeks, COGT’s price has moved between $3.72 and $17.15.
Annual sales at Healthcare sector company grew by 10.02% over the past five years. The company achieved an average annual earnings per share of 10.89%. With a float of $112.56 million, this company’s outstanding shares have now reached $113.93 million.
Cogent Biosciences Inc (COGT) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Cogent Biosciences Inc is 19.43%, while institutional ownership is 87.65%. The most recent insider transaction that took place on Jul 10 ’25, was worth 24,999,993. In this transaction Director of this company bought 2,777,777 shares at a rate of $9.00, taking the stock ownership to the 9,003,418 shares. Before that another transaction happened on Jan 14 ’25, when Company’s Chief Commercial Officer bought 43,750 for $7.60, making the entire transaction worth $332,412. This insider now owns 45,848 shares in total.
Cogent Biosciences Inc (COGT) Performance Highlights and Predictions
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.64 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.57) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.5 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 10.89% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.15% during the next five years compared to 10.02% growth over the previous five years of trading.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
Cogent Biosciences Inc (COGT) is currently performing well based on its current performance indicators. A quick ratio of 4.19 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.42, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -1.85 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Cogent Biosciences Inc (NASDAQ: COGT) saw its 5-day average volume 3.37 million, a positive change from its year-to-date volume of 1.98 million. As of the previous 9 days, the stock’s Stochastic %D was 40.34%.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 91.86%, which indicates a significant increase from 67.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.89 in the past 14 days, which was higher than the 0.63 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.79, while its 200-day Moving Average is $9.15. Nevertheless, the first resistance level for the watch stands at $16.68 in the near term. At $17.16, the stock is likely to face the second major resistance level. The third major resistance level sits at $17.76. If the price goes on to break the first support level at $15.60, it is likely to go to the next support level at $15.00. Assuming the price breaks the second support level, the third support level stands at $14.52.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
Market capitalization of the company is 2.26 billion based on 113,856K outstanding shares. Right now, sales total 0 K and income totals -255,860 K. The company made 0 K in profit during its latest quarter, and -73,530 K in sales during its previous quarter.
